Название продукции:Isoquinoline, 4-(3-bromophenyl)-6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-, (4S)-

IUPAC Name:(4S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline

CAS:1870821-29-6
Молекулярная формула:C16H14BrCl2N
Чистота:95%+
Номер в каталоге:CM429816
Молекулярная масса:371.1

Упаковочная единица Доступно для заказа Цена ($) Количество
CM429816-100mg in stock ƦNJȬ
CM429816-250mg in stock NJưŴ
CM429816-1g in stock ȬƦȬ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:1870821-29-6
Молекулярная формула:C16H14BrCl2N
Точка плавления:-
Smiles-код:CN1C[C@@H](C2=CC(Br)=CC=C2)C2=C(C1)C(Cl)=CC(Cl)=C2
Плотность:
Номер в каталоге:CM429816
Молекулярная масса:371.1
Точка кипения:
Номер Mdl:MFCD27939616
Хранение:

Category Infos

Tetrahydroisoquinolines
Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.

Column Infos

Tenapanor
FDA has approved XPHOZAH (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

XPHOZAH, with its unique blocking mechanism of action, acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3), reducing phosphate absorption through the paracellular pathway, the primary pathway of phosphate absorption.